Progestagens used in HRT have substantially distinct pharmacological pro-files.
The novel progestin drospirenone has antimineralocorticoid properties
which could have beneficial as well unfavorable effects on cardiovascular
Active safety surveillance using a prospective, controlled cohort study
design is a reliable method to compare drug utilization and safety of
new and established drugs under “real-life conditions”.